National Veterinary Institute
Fiscal Year 2013 EC (2021/2022 GC)
Revenue
ETB 172.4M
Net Profit
ETB 53.7M
Total Assets
ETB 751.6M
Total Equity
ETB 654.8M
Profit Breakdown
Key income statement items
Cash Flow Activities
Net cash from each activity
Asset Composition
Breakdown of total assets
Statement of Profit or Loss and Other Comprehensive Income
FY 2013 EC
| Item | Amount (ETB) |
|---|---|
| Revenue | |
| Revenue | 172,448,635 |
| Cost of sales | -65,709,795 |
| Gross profit | 106,738,839 |
| Other Income | |
| Other operating income | 6,878,693 |
| Gain for currency fluctuation | 5,434,523 |
| Total income | 119,052,056 |
| Operating Expenses | |
| General and administration expense | -42,374,030 |
| Allowance for doubtful debts | 0 |
| Audit fee | -39,500 |
| Board fee | -290,000 |
| Total operating expenses | -42,703,530 |
| Profit | |
| Operating profit | 76,348,526 |
| Finance costs | 0 |
| Profit before tax | 76,348,526 |
| Profit tax expense | -19,182,576 |
| Profit after tax | 57,165,951 |
| Deferred tax asset/(liability) movement | -3,453,501 |
| Net profit for the year | 53,712,450 |
Statement of Financial Position
As at end of FY 2013 EC
| Item | Amount (ETB) |
|---|---|
| Non-Current Assets | |
| Property, plant and equipment | 376,638,891 |
| Intangible asset | 836,269 |
| Investments in CBE & Government bond | 28,122,329 |
| Right of use asset - land | 3,441,248 |
| Non-current asset held for sale | 43,708 |
| Total non-current assets | 409,082,445 |
| Current Assets | |
| Inventories | 166,298,057 |
| Trade and other receivables | 13,630,455 |
| Advance and prepayments | 8,981,778 |
| Cash and short-term deposits | 153,575,522 |
| Total current assets | 342,485,811 |
| Total Assets | |
| Total assets | 751,568,256 |
| Equity | |
| Paid up capital | 40,189,122 |
| Donated capital | 105,502,960 |
| Capital reserve | 7,543,588 |
| Legal reserve | 8,037,824 |
| Retained earnings | 417,123,146 |
| Revaluation reserve | 76,429,663 |
| Total equity | 654,826,303 |
| Non-Current Liabilities | |
| Termination benefit liabilities | 3,975,589 |
| Deferred tax liabilities | 12,620,500 |
| Total non-current liabilities | 16,596,089 |
| Current Liabilities | |
| Trade and other payables | 60,898,166 |
| Other taxes and obligations | 2,543,923 |
| Profit tax payables | 16,703,775 |
| Total current liabilities | 80,145,864 |
| Total Liabilities & Equity | |
| Total liabilities | 96,741,953 |
| Total equity and liabilities | 751,568,256 |
Cash Flow Statement
FY 2013 EC
| Item | Amount (ETB) |
|---|---|
| Operating Activities | |
| Profit before tax | 76,348,526 |
| Depreciation | 16,247,853 |
| Amortization | 180,320 |
| Change in severance payable | 565,514 |
| (Gain)/Loss on disposal of PPE | 0 |
| Decrease in trade and other receivables | -8,261,061 |
| Increase in inventories | 36,743,691 |
| Increase in trade and other payables | -374,446 |
| Cash generated from operations | 121,450,397 |
| Withholding tax paid | -11,548,710 |
| Profit tax paid | -2,478,801 |
| Net cash from operating activities | 107,422,886 |
| Investing Activities | |
| Increase in time deposit | -1,772,429 |
| Purchase of property, plant and equipment | -139,349,420 |
| Purchase of intangible assets | 0 |
| Increase in construction in progress | 0 |
| Increase in assets held for sale | -41,708 |
| Net cash used in investing activities | -141,163,557 |
| Financing Activities | |
| Donation received | 56,013,550 |
| Net cash from financing activities | 56,013,550 |
| Net Change in Cash | 22,272,878 |
| Closing Cash & Equivalents | 153,575,521 |
Audit Findings
#1 Advance collected amounting to ETB 10,940,227.32 was treated as sales and undelivered sales were recorded against cost of sales; the auditors were not satisfied revenue should be recognized without performance obligations being satisfied.
Advance collected amounting to ETB 10,940,227.32 was treated as sales and undelivered sales were recorded against cost of sales; the auditors were not satisfied revenue should be recognized without performance obligations being satisfied.
Advance collected amounting to ETB 10,940,227.32 was treated as sales and undelivered sales were recorded against cost of sales; the auditors were not satisfied revenue should be recognized without performance obligations being satisfied.
Amount: ETB 10.9M
#2 Direct and indirect costs (material, labor, overhead) were not absorbed into inventory cost at year end; vaccines inventory was valued at opening standard costing; auditors were not satisfied inventory and cost of sales were fairly stated.
Direct and indirect costs (material, labor, overhead) were not absorbed into inventory cost at year end; vaccines inventory was valued at opening standard costing; auditors were not satisfied inventory and cost of sales were fairly stated.
Direct and indirect costs (material, labor, overhead) were not absorbed into inventory cost at year end; vaccines inventory was valued at opening standard costing; auditors were not satisfied inventory and cost of sales were fairly stated.
#3 Total sales per monthly VAT declaration and annual sales register machine (Z report) differed by Birr 7,413,400; Z report balance was higher; auditors noted non-compliance could lead to penalties.
Total sales per monthly VAT declaration and annual sales register machine (Z report) differed by Birr 7,413,400; Z report balance was higher; auditors noted non-compliance could lead to penalties.
Total sales per monthly VAT declaration and annual sales register machine (Z report) differed by Birr 7,413,400; Z report balance was higher; auditors noted non-compliance could lead to penalties.
Extracted from audited financial statements via OCR. Figures in Ethiopian Birr.